Reduced Early Mortality with Daratumumab-Based Frontline Therapy in Systemic AL Amyloidosis- Experience from the Columbia Amyloidosis Multidisciplinary Program

被引：1
|
作者：
Chakraborty, Rajshekhar [1 ]
Bhutani, Divaya [2 ]
Mapara, Markus [2 ]
Reshef, Ran [3 ]
Maurer, Mathew S. [4 ]
Radhakrishnan, Jai [5 ]
Lentzsch, Suzanne [6 ]
机构：
[1] Columbia Univ, Irving Med Ctr, Thornwood, NY USA
[2] Columbia Univ, Coll Phys & Surg, New York, NY USA
[3] Columbia Univ, Div Hematol & Oncol, Med Ctr, New York, NY USA
[4] New York Presbyterian Hosp, New York, NY USA
[5] New York Presbyterian Hosp, Columbia Campus, New York, NY USA
[6] Columbia Univ, Div Hematol & Oncol, Med Ctr, New York, NY USA
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-187214
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 15 条
  • [1] Reduced early mortality with Daratumumab-based frontline therapy in AL amyloidosis: A retrospective cohort study
    Chakraborty, Rajshekhar
    Bhutani, Divaya
    Mapara, Markus
    Reshef, Ran
    Maurer, Mathew S.
    Radhakrishnan, Jai
    Lentzsch, Suzanne
    AMERICAN JOURNAL OF HEMATOLOGY, 2024, 99 (03) : 477 - 479
  • [2] Timing and outcomes of second-line therapy in the era of daratumumab-based frontline therapy in AL amyloidosis
    Bazarbachi, Abdul-Hamid
    Bhutani, Divaya
    Radhakrishnan, Jai
    Mapara, Markus
    Maurer, Mathew S.
    Lentzsch, Suzanne
    Chakraborty, Rajshekhar
    AMERICAN JOURNAL OF HEMATOLOGY, 2024, 99 (11) : 2225 - 2228
  • [3] Outcomes of Patients with AL Amyloidosis after Failure of Daratumumab-Based Therapy
    Theodorakakou, Foteini
    Spiliopoulou, Vasiliki
    Fotiou, Despina
    Roussou, Maria
    Malandrakis, Panagiotis
    Ntanasis-Stathopoulos, Ioannis
    Migkou, Magdalini
    Papaiakovou, Evangelos Eleutherakis
    Kanellias, Nikolaos
    Papanikolaou, Asimina
    Gavriatopoulou, Maria
    Terpos, Evangelos
    Dimopoulos, Meletios-Athanasios
    Kastritis, Efstathios
    BLOOD, 2022, 140 : 4275 - 4276
  • [4] Daratumumab-based therapy in patients with heavily-pretreated AL amyloidosis
    Abeykoon, Jithma P.
    Zanwar, Saurabh
    Dispenzieri, Angela
    Gertz, Morie A.
    Leung, Nelson
    Kourelis, Taxiarchis
    Gonsalves, Wilson
    Muchtar, Eli
    Dingli, David
    Lacy, Martha Q.
    Hayman, Suzanne R.
    Buadi, Francis
    Warsame, Rahma
    Kyle, Robert A.
    Rajkumar, Vincent
    Kumar, Shaji
    Kapoor, Prashant
    LEUKEMIA, 2019, 33 (02) : 531 - 536
  • [5] Daratumumab-based therapy in patients with heavily-pretreated AL amyloidosis
    Jithma P. Abeykoon
    Saurabh Zanwar
    Angela Dispenzieri
    Morie A. Gertz
    Nelson Leung
    Taxiarchis Kourelis
    Wilson Gonsalves
    Eli Muchtar
    David Dingli
    Martha Q. Lacy
    Suzanne R. Hayman
    Francis Buadi
    Rahma Warsame
    Robert A. Kyle
    Vincent Rajkumar
    Shaji Kumar
    Prashant Kapoor
    Leukemia, 2019, 33 : 531 - 536
  • [6] Pattern of Use and Efficacy of Daratumumab-Based Therapy in Patients with AL Amyloidosis: A Single Institution Experience
    Dima, Danai
    Hu, Xiao
    Dower, Joshua
    Comenzo, Raymond L.
    Varga, Cindy
    BLOOD, 2020, 136
  • [7] High-dose melphalan-autologous hematopoietic cell transplantation in systemic AL amyloidosis following daratumumab-based frontline therapy
    Mellgard, George S.
    Bhutani, Divaya
    Mapara, Markus Y.
    Maurer, Mathew S.
    Radhakrishnan, Jai
    Lentzsch, Suzanne
    Chakraborty, Rajshekhar
    BONE MARROW TRANSPLANTATION, 2024, 59 (08) : 1181 - 1183
  • [8] Outcomes of patients with light chain (AL) amyloidosis after failure of daratumumab-based therapy
    Theodorakakou, Foteini
    Fotiou, Despina
    Spiliopoulou, Vasiliki
    Roussou, Maria
    Malandrakis, Panagiotis
    Ntanasis-Stathopoulos, Ioannis
    Migkou, Magdalini
    Eleutherakis-Papaiakovou, Evangelos
    Kanellias, Nikolaos
    Papanikolaou, Asimina
    Gavriatopoulou, Maria
    Terpos, Evangelos
    Dimopoulos, Meletios A.
    Kastritis, Efstathios
    BRITISH JOURNAL OF HAEMATOLOGY, 2023, 203 (03) : 411 - 415
  • [9] Daratumumab for the treatment of relapsed/refractory AL amyloidosis: experience from the amyloidosis Program of Calgary (APC)
    Levin, Daniel
    Lewis, Ellen
    McCulloch, Sylvia
    Lee, Holly
    Tay, Jason
    Duggan, Peter
    Neri, Paola
    Bahlis, Nizar
    Jimenez-Zepeda, Victor H.
    LEUKEMIA & LYMPHOMA, 2024, 65 (03) : 403 - 406
  • [10] Referral patterns in AL and ATTR Amyloidosis: initial experience from the Amyloidosis Program of Calgary: role of a multidisciplinary approach
    Zepeda, Victor Jimenez
    Burande, Aksha
    Fine, Nowell
    Miller, Robert
    Hahn, Christopher
    Mahe, Etienne
    Bosley, Debra
    Litwin, Lyndsay
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2024, 31 : S125 - S126
12